CN120417894A - 脑神经细胞保护用组合物 - Google Patents

脑神经细胞保护用组合物

Info

Publication number
CN120417894A
CN120417894A CN202380089042.4A CN202380089042A CN120417894A CN 120417894 A CN120417894 A CN 120417894A CN 202380089042 A CN202380089042 A CN 202380089042A CN 120417894 A CN120417894 A CN 120417894A
Authority
CN
China
Prior art keywords
composition
docosahexaenoic acid
acid
lutein
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380089042.4A
Other languages
English (en)
Chinese (zh)
Inventor
森田贤
末安俊明
安本启甫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of CN120417894A publication Critical patent/CN120417894A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202380089042.4A 2022-12-26 2023-12-19 脑神经细胞保护用组合物 Pending CN120417894A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2022-208134 2022-12-26
JP2022208134 2022-12-26
JP2023061431 2023-04-05
JP2023-061431 2023-04-05
PCT/JP2023/045395 WO2024143060A1 (ja) 2022-12-26 2023-12-19 脳神経細胞保護用組成物

Publications (1)

Publication Number Publication Date
CN120417894A true CN120417894A (zh) 2025-08-01

Family

ID=91717479

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380089042.4A Pending CN120417894A (zh) 2022-12-26 2023-12-19 脑神经细胞保护用组合物

Country Status (4)

Country Link
JP (1) JPWO2024143060A1 (https=)
CN (1) CN120417894A (https=)
TW (1) TW202434198A (https=)
WO (1) WO2024143060A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6178761B2 (ja) * 2013-07-10 2017-08-09 ライオン株式会社 内服剤
TWI790238B (zh) * 2017-06-01 2023-01-21 日商參天製藥股份有限公司 含有葉黃素類或其鹽及菱屬植物加工物之腦之錐體細胞的減少抑制劑
GB201720119D0 (en) * 2017-12-04 2018-01-17 Howard Foundation Holdings Ltd Prevention and/or treatment of neurodegenerative disease

Also Published As

Publication number Publication date
TW202434198A (zh) 2024-09-01
WO2024143060A1 (ja) 2024-07-04
JPWO2024143060A1 (https=) 2024-07-04

Similar Documents

Publication Publication Date Title
JP5985138B2 (ja) エネルギー消費促進剤
US20090047304A1 (en) Composition For Body Fat Reduction
JP6335508B2 (ja) 成長ホルモン分泌促進剤
US20120309716A1 (en) Motor Function Improver
US20160067270A1 (en) Use of ginsenoside f2 for prophylaxis and treatment of liver disease
JPH11246399A (ja) 脂質代謝改善組成物
KR100828069B1 (ko) 푸코잔틴 또는 이를 함유하는 해조류 추출물을 포함하는,지방간의 예방 또는 치료용 조성물
WO2021230145A1 (ja) ニコチンアミドアデニンジヌクレオチド（ｎａｄ）濃度上昇剤
JP5985226B2 (ja) 過活動膀胱の予防又は改善剤
CN120417894A (zh) 脑神经细胞保护用组合物
JP7229513B2 (ja) 脳の機能改善剤および脳の機能改善用飲食品
KR20100088007A (ko) 율피 추출물을 포함하는 지방간의 예방 또는 치료용 조성물
JP5071618B2 (ja) 外分泌腺の機能障害改善剤及び機能障害改善用飲食物
KR101174301B1 (ko) 유황을 섭취한 파리 유충 추출물을 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 조성물
KR20140104090A (ko) 커큐민을 유효성분으로 포함하는 지방간 질환의 치료 또는 예방용 조성물
HK40128991A (zh) 脑神经细胞保护用组合物
KR20190003570A (ko) 안전한·안정된 플라스마로겐과 그 제제 및 인지증의 미병 상태의 판정 방법
JP5196708B2 (ja) アスタキサンチン及び／又はそのエステルを有効成分とする筋萎縮改善剤及び飲食物
JP4997514B2 (ja) 血圧上昇抑制剤
KR102909154B1 (ko) 메틸 리놀레산을 포함하는 지방간 질환의 개선, 예방 또는 치료용 약학적 조성물
JP2006045120A (ja) 脂肪分解促進剤、並びに化粧料及び飲食物
KR20090083263A (ko) 진저롤을 함유하는 알코올성 태아기형 예방 및 치료용조성물
KR20250008755A (ko) 혈관 내피 기능 개선용 조성물
TW202502321A (zh) 含有芝麻素類化合物及阿魏酸或其鹽之組成物
JP2021161069A (ja) 食後血中中性脂肪上昇抑制剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40128991

Country of ref document: HK